首页> 外文期刊>Indian journal of palliative care >Low-dose oral ketamine as a procedural analgesia in pediatric cancer patients undergoing bone marrow aspirations at a resource-limited cancer hospital in India
【24h】

Low-dose oral ketamine as a procedural analgesia in pediatric cancer patients undergoing bone marrow aspirations at a resource-limited cancer hospital in India

机译:小剂量口服氯胺酮作为在印度资源有限的癌症医院接受骨髓抽吸术的小儿癌症患者的手术镇痛

获取原文
       

摘要

Aim: Many pediatric cancer patients undergo repeated bone marrow aspirations (BMAs) for diagnostic and treatment evaluation purposes. Full anesthesia is the standard of care during this procedure in high-income countries. At hospitals with low resources in low/middle-income countries many children undergo these painful procedures without sufficient pain relief. This study aimed to evaluate the usefulness of low-dose oral ketamine as a procedural analgesic in a low-resource pediatric cancer care department. Materials and Methods: Pediatric patients, 4–15 years of age, who underwent BMAs between September 31 and November 30, 2018, were invited to participate. The study was designed as a placebo-controlled, single-blinded trial with three trial groups. Group K received 1.0 mg/kg of ketamine and Group KM received 1.0 mg/kg ketamine with an addition of 0.2 mg/kg midazolam, mixed in juice 30 min before procedures. Group P received placebo consisting of plain juice. All three groups also received the hospital's current standard treatment for procedural pain in BMAs. Patients and caregivers assessed the procedural pain, as did the performing doctors. For the patients, Faces Pain Scale – Revised was used and the Numeric Rating Scale-11 for caregivers and doctors. Results: A total of 87 patients were included in the study distributed with 29 in Group K, 29 in Group KM, and 29 in Group P. Seven patients were excluded, one patient denied participation and the remaining did not meet the inclusion criteria. There was no significant difference between the pain reported by the groups. A total of 69% patients in Group KM and 35% in Group K had somnolence reported as a side effect compared to 14% in Group P. Conclusion: We found no significant effects on the procedural pain in any of the treatment groups compared to placebo. There were only mild side effects. The doses of ketamine might be insufficient for this painful and stressful procedure.
机译:目的:许多儿科癌症患者出于诊断和治疗评估目的而反复进行骨髓穿刺(BMA)。在高收入国家,全麻是此过程中的护理标准。在中低收入国家资源贫乏的医院中,许多孩子接受了这些痛苦的手术,而疼痛却没有得到充分缓解。这项研究旨在评估低剂量口服氯胺酮在低资源儿科癌症护理部门中作为手术镇痛剂的有效性。材料和方法:邀请4-15岁的小儿患者于2018年9月31日至11月30日接受BMA治疗。该研究设计为具有三个试验组的安慰剂对照单盲试验。 K组接受1.0 mg / kg的氯胺酮,KM组接受1.0 mg / kg的氯胺酮,另外加入0.2 mg / kg的咪达唑仑,在手术前30分钟与果汁混合。 P组接受安慰剂,包括纯汁。这三组患者均接受了医院目前针对BMA程序性疼痛的标准治疗方法。患者和护理人员以及手术医生对手术疼痛进行了评估。对于患者,使用了“经修订的面部疼痛量表”,以及护理人员和医生的“ 11级数字量表”。结果:总共纳入了87例患者,其中K组29例,KM组29例,P组29例。排除了7例患者,其中1例患者拒绝参与,其余不符合纳入标准。各组报告的疼痛之间无显着差异。据报道,KM组中有69%的患者有副作用,K组中有35%的患者有嗜睡,而P组中只有14%。结论:与安慰剂相比,我们发现任何治疗组对程序性疼痛均无显着影响。只有轻微的副作用。氯胺酮的剂量可能不足以应付这种痛苦和紧张的手术。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号